News and Events


  • May is Brain Cancer Awareness Month

    May 2023

    There is no better time to raise awareness and vital funds to help change the statistics around brain cancer.

    - Brain Cancer kills more children than any other disease.
    - Brain Cancer kills more people under 40 than any other cancer.

    There have been no major breakthroughs in brain cancer in over 40 years and yet other cancers have improved their prognosis! It’s time we made the same breakthroughs in brain cancer treatments and changed the outcomes for those diagnosed with this terrible disease.

    The Brain Cancer Collective – our charity arm – will be holding its flagship fundraising event the Bike Ride for Brain Cancer this month on 5th-6th May – a 2 day ride from Hornsby to the Hunter Valley to raise the vital funds we need to continue our important work.

    Please help us spread the word and raise funds this month.

    Personal fundraising events can be set up on our website
    Or Donate to the Bike Ride for Brain Cancer event

  • BCBA Consortium Member Steps Up

    April 2023

    We are delighted to welcome Michelle Burke as the latest member of the BCBA Steering Committee. Michelle is a highly recognised adviser to the pharmaceutical and biotech industry and a strong advocate for patient access to new therapies. She is currently the industry nominated member on the Pharmaceutical Benefits Advisory Committee and a non-executive director on health-related boards. Michelle also represented the industry on the inaugural Australian Brain Cancer Mission Strategic Advisory Group – a role that has given her considerable insight into the challenges facing both patients and researchers in the world of brain cancer.

    ‘I am extremely honoured to join such an eminent and passionate group on the BCBA Steering Committee. There is much to do to improve well-being for those facing brain cancer, and through BCBA I am looking forward to contributing to that goal.’ – Michelle Burke

  • Huge Boost for Australian Brain Cancer Research!

    March 2023

    We are thrilled to share the news that Brain Cancer Biobanking Australia and a large team of clinicians, researchers and healthcare specialists from across the country have been awarded a $6 million MRFF grant to advance Australia’s capability for brain cancer research and patient care.

    “The significance of this grant cannot be overstated. These funds will enable our national team to establish an integrated network of research platforms that will not just be an Australian-first, but a world-first in brain cancer.” - BCBA Chair and Project Lead, Associate Professor Lindy Jeffree

    Thank you to all our collaborators and partners. We can’t wait to work with you on this important national initiative and develop the research infrastructure Australia needs to transform the lives of people diagnosed with brain cancer. Read more here.

  • Bike Ride for Brain Cancer - Shining the Spotlight on Andrew Boak

    February 2023

    Andrew Boak is Chief Economist (Aust/NZ) at Goldman Sachs and a Director on the Board of our charity arm, the Brain Cancer Collective. 

    Andrew was also a school friend of Lucie Leonard - the inspiration behind Brain Cancer Biobanking Australia - who was only 34 when she lost her seven-year battle with brain cancer in 2012. In May, he will be joining many others on the road to a cure in the 2023 Bike Ride for Brain Cancer – his 5th ride to date.

    “Sadly, we’ve all likely been touched by cancer in some way. This ride is such a wonderful way to remember Lucie, support those suffering today, and accelerate progress to a cure.” – Andrew Boak.

    We hope that everyone will get behind Andrew and sponsor to his fundraising effort for BCBA.

    Or better still, join him and the amazing camaraderie on the road - sign up to ride!

  • Australia Day Honour

    January 2023

    A very big congratulations to our Founder and Director, Robyn Leonard, who has been awarded the Medal of the Order of Australia (OAM) in the Australia Day Honours List for her service to community health and medical research. 

    “This well-deserved recognition barely scratches the surface of the time, energy and enthusiasm that Robyn Leonard has directed towards improving the care of patients with brain cancer” Associate Professor Lindy Jeffree, Chair BCBA

  • Happy Holidays to our Collaborators and Supporters

    December 2022

    What an amazing year we have had! Thank you to all our wonderful collaborators and supporters for making this year possible. With your help we have seen some remarkable growth and progress throughout BCBA and BCC. 

    We can’t wait to reconnect in the new year and see what we can continue to achieve together! 

    Wishing everyone a happy, safe and restful holiday season.

  • Remembering the Inspiration behind BCBA

    November 2022

    This month marks the 10-year anniversary of the passing of Lucie Leonard. Lucie is the inspiration behind Brain Cancer Biobanking Australia and the daughter of Founder Robyn Leonard. Lucie was diagnosed with brain cancer at the age of 27 and sadly lost her seven-year battle in 2012.

    Through Lucie’s tragic journey with brain cancer, it became very clear to Robyn that there was a desperate need for more research into this cruel disease. Despite killing more children in Australia than any other disease and more people under 40 than any other cancer, brain cancer remains one of the most under-researched of all cancers.

    Robyn quickly became a passionate brain cancer consumer advocate, establishing both Brain Cancer Biobanking Australia and its charity arm, the Brain Cancer Collective, to enable a collaborative approach to providing researchers with access to the tissue and data they need to make real breakthroughs in brain cancer research.

    “BCBA is Lucie’s legacy. Her courage and resilience in the face of this disease was incredible and continues to inspire me. I want to do everything I can to help researchers find effective treatments for brain cancer. It is achievable, we just need more funding.” - Robyn Leonard

    Join us on the road to a cure in BCBA’s major fundraising event, the Bike Ride for Brain Cancer. You can learn more about the 2023 event or register your interest to ride here.

  • Going the Distance for Brain Cancer Research!

    October 2022

    Last month twin brothers, Jonathan and Benjamin Siero, embarked on a monumental 3500km bike ride from Fremantle to Melbourne to honour their stepfather who was diagnosed with brain cancer in 2021 and raise much needed funds for research.

    Brain cancer can affect anyone and everyone, even those closest to you. I’m looking to bring awareness to brain cancer and hopefully reach our fundraising target to support the Brain Cancer Collective - Jonathan Siero.

    Sisters, Jenny Tierney & Melissa Peros, took on their epic cycle challenge from home. Riding 1528kms non-stop on their beloved father’s exercise bike in his memory and for all those like him, who lost their lives to brain cancer last year.   

    It is a cruel disease that robs you of your loved one right before your eyes, before they themselves are even aware of it, yet there is very little research into brain cancer - Melissa Peros.

    Please donate to support: The Siero’s and Jenny & Melissa

  • A Novel Approach in Brain Cancer Clinical Trials

    September 2022

    The clinical trial landscape is dominated by new drugs and treatment - but what if only a small change to an already established, standard treatment could lead to better outcomes? BCBA Steering Committee member, A/Prof Craig Gedye, is leading this novel approach with the establishment of the MAGMA (Multi-Arm GlioblastoMa Australasia) clinical trial.

    “We’re aiming to use multiple innovations in trial design to test changes in the way we use our existing treatments for brain cancer; changes we hope will have big impacts for future patients,” Gedye said.

    The trial is currently testing temozolomide – a chemotherapy drug commonly used to treat brain cancer – and making simple adjustments to when and how it is delivered within the current treatment protocol.

    “These kinds of simple questions have led to significant improvements in other cancers”, he said
    “It’s changed how we recommend treatment to people with prostate cancer, ovarian cancer and other cancers”.

    The MAGMA trial is currently open at hospitals across Australia for people newly diagnosed with glioblastoma (GBM). Please click here for more information. 

  • Advancing Brain Cancer Research in the ACT

    August 2022

    BCBA consortium member Professor Leonie Quinn has developed the ACT’s first brain cancer biobank. The Head of Genome Science and Cancer Division at John Curtin School of Medical Research established the Canberra Brain Cancer Collaborative to enable biobanking and genomic-based brain cancer research, to benefit patients in the ACT and around the world.

    “I am looking forward to building our collection and ensuring the samples are accessible to all Australian researchers as part of BCBA’s National Brain Cancer Biospecimen Register,” she said.

    The new biobank will support the clinical research of Professor Quinn’s lab to better understand and identify mutations driving brain cancer and make important progress in developing new personalised brain cancer treatments.

    “This will be critical for enabling targeted drug discovery research and improved outcomes for patients”.

  • ABC Andrew Olle Media Lecture Charity Partner

    July 2022

    We are delighted that BCBA’s fundraising arm, the Brain Cancer Collective (BCC), has been chosen as charity partner for the ABC’s Andrew Olle Media Lecture. The event is held annually to honour one of Australia’s most iconic broadcasters, Andrew Olle, who lost his life to brain cancer.

    BCC Chair, Professor Michael Besser AM and Directors, Robyn Leonard and Sharon Bell were privileged to share the BCBA/BCC story to raise awareness and much needed funds at this prestigious media event.  

  • Collaborating in Brain Cancer Research and Clinical Trials

    June 2022

    Associate Professor Eng-Siew Koh brings a unique perspective to the BCBA Steering Committee. An academic radiation oncologist and Chair of the Cooperative Trials Group for Neuro-Oncology (COGNO), Koh represents the leap from research enabled by BCBA tissue banking into clinical trials.

    “Moving from the lab to the patient space via clinical trials requires collaboration at the highest level – and I am honoured to be part of that team approach.”

    A/Prof Koh describes her role as COGNO Chair as her biggest professional achievement. She is committed to its broad portfolio of clinical trials and driven by the intellectual challenge of research,

    “I enjoy the opportunity to make a contribution to progressing knowledge and ultimately improving outcomes for brain cancer patients,” she said.

Click here to view archived news items


  • Bike Ride for Brain Cancer

    5th - 6th May 2023

    BCBA’s fundraising arm, the Brain Cancer Collective, will hold its annual 2 day 250km Bike Ride for Brain Cancer on 5th and 6th May in 2023. The riders will regroup for the boutique event that takes a scenic route from Sydney to the Hunter Valley and finishes in the beautiful grounds of Calais Estate Winery. We hope that you will support our efforts to advance brain cancer research by visiting our website to register your interest.